[Federal Register Volume 79, Number 164 (Monday, August 25, 2014)]
[Notices]
[Pages 50653-50654]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-20101]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-14-14AUI]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    The Centers for Disease Control and Prevention (CDC), as part of 
its continuing effort to reduce public burden, invites the general 
public and other Federal agencies to take this opportunity to comment 
on proposed and/or continuing information collections, as required by 
the Paperwork Reduction Act of 1995. To request more information on the 
below proposed project or to obtain a copy of the information 
collection plan and instruments, call 404-639-7570 or send comments to 
Leroy A. Richardson, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or 
send an email to [email protected].
    Comments submitted in response to this notice will be summarized 
and/or included in the request for Office of Management and Budget 
(OMB) approval. Comments are invited on: (a) Whether the proposed 
collection of information is necessary for the proper performance of 
the functions of the agency, including whether the information shall 
have practical utility; (b) the accuracy of the agency's estimate of 
the burden of the proposed collection of information; (c) ways to 
enhance the quality, utility, and clarity of the information to be 
collected; (d) ways to minimize the burden of the collection of 
information on respondents, including through the use of automated 
collection techniques or other forms of information technology; and (e) 
estimates of capital or start-up costs and costs of operation, 
maintenance, and purchase of services to provide information. Burden 
means the total time, effort, or financial resources expended by 
persons to generate, maintain, retain, disclose or provide information 
to or for a Federal agency. This includes the time needed to review 
instructions; to develop, acquire, install and utilize technology and 
systems for the purpose of collecting, validating and verifying 
information, processing and maintaining information, and disclosing and 
providing information; to train personnel and to be able to respond to 
a collection of information, to search data sources, to complete and 
review the collection of information; and to transmit or otherwise 
disclose the information. Written comments should be received within 60 
days of this notice.

Proposed Project

    WISEWOMAN National Program Evaluation--New--National Center for 
Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for 
Disease Control and Prevention (CDC).

Background and Brief Description

    The CDC has supported the WISEWOMAN program (Well-Integrated 
Screening and Evaluation for Women Across the Nation) since 1995. The 
WISEWOMAN program is designed to serve low-income women ages 40-64 who 
have elevated risk factors for cardiovascular disease (CVD) and have no 
health insurance, or are underinsured for medical and preventive care 
services. Through the WISEWOMAN program, women have access to screening 
services for selected CVD risk factors such as elevated blood 
cholesterol, hypertension, and abnormal blood glucose levels; referrals 
to lifestyle programs; and referrals to medical care. WISEWOMAN 
participants must be co-enrolled in the CDC-sponsored National Breast 
and Cervical Cancer Early Detection Program (NBCCEDP).
    The WISEWOMAN program is administered through cooperative 
agreements with state, territorial, or tribal health departments. At 
present, approximately two-thirds of program funding is provided by CDC 
with the other one-third supplied by the state, territory, or tribal 
organization. Each WISEWOMAN awardee submits to CDC an annual progress 
report that describes program objectives and activities, and semi-
annual data reports (known as minimum data elements, or MDE) on the 
screening, assessment, and lifestyle program services offered to women 
who participate in the program (see WISEWOMAN Reporting System, OMB No. 
0920-0612, exp. 12/31/2016). Participant-level MDE are de-identified 
prior to transmission to CDC.
    In 2013, CDC released the fourth funding opportunity announcement 
(FOA) for the WISEWOMAN program (DP13-1302), which resulted in four-
year cooperative agreements with 22 state, territorial, and tribal 
health departments, including 5 new and 17 continuing awardees from the 
previous FOA. Key program elements were retained (e.g., provision of 
screening services, promotion of healthy lifestyle behaviors, and 
linkage to community resources), but a number of changes were 
incorporated into the program at that time due to shifts in 
populations, systems, and community needs. The current FOA reflects 
increased emphasis on improving access to clinical systems of care and 
increased emphasis on

[[Page 50654]]

leveraging existing resources in the community. Lifestyle interventions 
have also been reframed to include lifestyle programs (LSPs) and health 
coaching (HC) sessions, and MDE have been updated to capture 
information about risk reduction counseling and participants' readiness 
to change. The current cooperative agreement also stresses monitoring 
and performance evaluation as key program dimensions. Additionally, 
more information is needed to augment that from previous evaluation 
efforts.
    CDC seeks to conduct a one-time, multi-component evaluation to 
assess the effectiveness of the program on individual-, organizational-
, and community-level outcomes. The in-depth assessment is designed to 
complement the routine progress and MDE information already being 
collected from WISEWOMAN program awardees. The new data collection will 
focus on obtaining qualitative and quantitative information at the 
organizational and community levels about process and procedures 
implemented, and barriers, facilitators, and other contextual factors 
that affect program implementation and participant outcomes. Data 
collection activities will include a Program Survey with all WISEWOMAN 
awardee programs, administered in the second and fourth program years; 
a Network Survey of WISEWOMAN awardees and partner organizations, also 
conducted in the second and fourth program years; and a one-time Site 
Visit to a subset of awardees across the second to fourth program 
years. During site visits, semi-structured interviews will be conducted 
with WISEWOMAN staff members who serve in diverse roles and are 
positioned to provide a variety of perspectives on program 
implementation.
    OMB approval is requested for three years. Participation is 
voluntary and there are no costs to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden per     Total burden
      Type of respondents           Form name       respondents    responses per   response (in     (in hours)
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
WISEWOMAN Awardee               Program Survey..              15               1           70/60              18
 Administrators.
                                Network Survey..              15               1           50/60              13
                                Site Visit                     6               1           75/60               8
                                 Interview Guide.
Awardee Partners..............  Network Survey..             147               1           50/60             123
                                Site Visit                    12               1           45/60               9
                                 Interview Guide.
Healthy Behavior Support staff  Site Visit                    12               1           45/60               9
                                 Interview Guide.
Clinical Providers............  Site Visit                    12               1           45/60               9
                                 Interview Guide.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............             189
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-20101 Filed 8-22-14; 8:45 am]
BILLING CODE 4163-18-P